Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GY.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.107EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
XBB.1.5.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.67EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.88EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.48EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
FH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
GB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.79EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EU.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used